Skip to main content

The Cooperative Human Tissue Network of the National Cancer Institute: Supporting Cancer Research for 35 Years.

Publication ,  Journal Article
McCall, SJ; Lubensky, IA; Moskaluk, CA; Parwani, A; Radin, K; Ramirez, NC; Von Menchhofen, Z; Washington, MK; LiVolsi, VA
Published in: Mol Cancer Ther
October 2, 2023

The Cooperative Human Tissue Network was created by the NCI in 1987 to support a coordinated national effort to collect and distribute high quality, pathologist-validated human tissues for cancer research. Since then, the network has expanded to provide different types of tissue samples, blood and body fluid samples, immunohistologic and molecular sample preparations, tissue microarrays, and clinical datasets inclusive of biomarkers and molecular testing. From inception through the end of 2021, the network has distributed 1,375,041 biospecimens. It served 889 active investigators in 2021. The network has also taken steps to begin to optimize the representation of diverse communities among the distributed biospecimens. In this article, the authors review the 35-year history of this network, describe changes to the program over the last 15 years, and provide operational and scientific highlights from each of the divisions. Readers will learn how to engage with the network and about the continued evolution of the program for the future.

Duke Scholars

Published In

Mol Cancer Ther

DOI

EISSN

1538-8514

Publication Date

October 2, 2023

Volume

22

Issue

10

Start / End Page

1144 / 1153

Location

United States

Related Subject Headings

  • United States
  • Oncology & Carcinogenesis
  • Neoplasms
  • National Cancer Institute (U.S.)
  • Humans
  • Biomarkers
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McCall, S. J., Lubensky, I. A., Moskaluk, C. A., Parwani, A., Radin, K., Ramirez, N. C., … LiVolsi, V. A. (2023). The Cooperative Human Tissue Network of the National Cancer Institute: Supporting Cancer Research for 35 Years. Mol Cancer Ther, 22(10), 1144–1153. https://doi.org/10.1158/1535-7163.MCT-22-0714
McCall, Shannon J., Irina A. Lubensky, Christopher A. Moskaluk, Anil Parwani, Kiley Radin, Nilsa C. Ramirez, Zachery Von Menchhofen, Mary K. Washington, and Virginia A. LiVolsi. “The Cooperative Human Tissue Network of the National Cancer Institute: Supporting Cancer Research for 35 Years.Mol Cancer Ther 22, no. 10 (October 2, 2023): 1144–53. https://doi.org/10.1158/1535-7163.MCT-22-0714.
McCall SJ, Lubensky IA, Moskaluk CA, Parwani A, Radin K, Ramirez NC, et al. The Cooperative Human Tissue Network of the National Cancer Institute: Supporting Cancer Research for 35 Years. Mol Cancer Ther. 2023 Oct 2;22(10):1144–53.
McCall, Shannon J., et al. “The Cooperative Human Tissue Network of the National Cancer Institute: Supporting Cancer Research for 35 Years.Mol Cancer Ther, vol. 22, no. 10, Oct. 2023, pp. 1144–53. Pubmed, doi:10.1158/1535-7163.MCT-22-0714.
McCall SJ, Lubensky IA, Moskaluk CA, Parwani A, Radin K, Ramirez NC, Von Menchhofen Z, Washington MK, LiVolsi VA. The Cooperative Human Tissue Network of the National Cancer Institute: Supporting Cancer Research for 35 Years. Mol Cancer Ther. 2023 Oct 2;22(10):1144–1153.

Published In

Mol Cancer Ther

DOI

EISSN

1538-8514

Publication Date

October 2, 2023

Volume

22

Issue

10

Start / End Page

1144 / 1153

Location

United States

Related Subject Headings

  • United States
  • Oncology & Carcinogenesis
  • Neoplasms
  • National Cancer Institute (U.S.)
  • Humans
  • Biomarkers
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1112 Oncology and Carcinogenesis